Colgate-Palmolive (NYSE:CL) Posts Earnings Results, Beats Expectations By $0.01 EPS

Colgate-Palmolive (NYSE:CL) posted its quarterly earnings results on Friday. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01, RTT News reports. Colgate-Palmolive had a net margin of 14.27% and a return on equity of 405.81%. During the same period in the previous year, the firm earned $0.87 EPS. Colgate-Palmolive updated its FY 2025 guidance to EPS.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock traded down $4.37 on Friday, hitting $86.52. The company had a trading volume of 5,369,893 shares, compared to its average volume of 5,076,352. Colgate-Palmolive has a 52 week low of $82.68 and a 52 week high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The company has a market cap of $70.69 billion, a PE ratio of 24.82, a PEG ratio of 3.70 and a beta of 0.44. The business has a 50-day simple moving average of $91.52 and a 200-day simple moving average of $97.25.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.31%. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.31%.

Insider Buying and Selling

In other news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 0.34% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

CL has been the topic of several research analyst reports. UBS Group reduced their price target on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research report on Thursday, January 16th. Barclays reduced their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. TD Cowen dropped their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Finally, StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $102.00.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.